Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP776348.RAbv6XZY1KK_bOLwWsq38Vgx0VJ3ezs-XTVa7X4p9yk0o130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP776348.RAbv6XZY1KK_bOLwWsq38Vgx0VJ3ezs-XTVa7X4p9yk0o130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP776348.RAbv6XZY1KK_bOLwWsq38Vgx0VJ3ezs-XTVa7X4p9yk0o130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP776348.RAbv6XZY1KK_bOLwWsq38Vgx0VJ3ezs-XTVa7X4p9yk0o130_provenance.
- befree-2016 importedOn "2016-02-19" NP776348.RAbv6XZY1KK_bOLwWsq38Vgx0VJ3ezs-XTVa7X4p9yk0o130_provenance.
- NP776348.RAbv6XZY1KK_bOLwWsq38Vgx0VJ3ezs-XTVa7X4p9yk0o130_assertion wasGeneratedBy ECO_0000203 NP776348.RAbv6XZY1KK_bOLwWsq38Vgx0VJ3ezs-XTVa7X4p9yk0o130_provenance.
- NP776348.RAbv6XZY1KK_bOLwWsq38Vgx0VJ3ezs-XTVa7X4p9yk0o130_assertion wasDerivedFrom befree-2016 NP776348.RAbv6XZY1KK_bOLwWsq38Vgx0VJ3ezs-XTVa7X4p9yk0o130_provenance.
- NP776348.RAbv6XZY1KK_bOLwWsq38Vgx0VJ3ezs-XTVa7X4p9yk0o130_assertion SIO_000772 19920204 NP776348.RAbv6XZY1KK_bOLwWsq38Vgx0VJ3ezs-XTVa7X4p9yk0o130_provenance.
- NP776348.RAbv6XZY1KK_bOLwWsq38Vgx0VJ3ezs-XTVa7X4p9yk0o130_assertion evidence source_evidence_literature NP776348.RAbv6XZY1KK_bOLwWsq38Vgx0VJ3ezs-XTVa7X4p9yk0o130_provenance.
- NP776348.RAbv6XZY1KK_bOLwWsq38Vgx0VJ3ezs-XTVa7X4p9yk0o130_assertion description "[Because most ER-negative breast tumors express mutant p53, our results provide the foundation for future development of p38 inhibitors to target p38 for the treatment of p53 mutant and ER-negative breast cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP776348.RAbv6XZY1KK_bOLwWsq38Vgx0VJ3ezs-XTVa7X4p9yk0o130_provenance.